語系:
繁體中文
English
說明(常見問題)
圖資館首頁
登入
回首頁
到查詢結果
[ subject:"Immunotherapy" ]
切換:
標籤
|
MARC模式
|
ISBD
Animal models for the development of cancer immunotherapy
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Animal models for the development of cancer immunotherapyedited by Seng-Lai Tan.
其他作者:
Tan, Seng-Lai.
出版者:
Hoboken, NJ :Wiley,2022.
面頁冊數:
1 online resource.
標題:
TumorsTreatment.
電子資源:
https://onlinelibrary.wiley.com/doi/book/10.1002/9781119535331
ISBN:
9781119535331$q(electronic bk.)
Animal models for the development of cancer immunotherapy
Animal models for the development of cancer immunotherapy
[electronic resource] /edited by Seng-Lai Tan. - Hoboken, NJ :Wiley,2022. - 1 online resource.
Includes bibliographical references and index.
"There has been an explosion of preclinical and clinical research leading to FDA approvals of immunotherapies that harness or enhance a patient's immune system to target tumors. However, despite promising clinical results, checkpoint blockade therapies can show intrinsic and acquired resistance and only certain tumor types respond more favorably than others. Animal models are valuable tools for studying these issues and for the preclinical evaluation of immune modulators"--
ISBN: 9781119535331$q(electronic bk.)Subjects--Topical Terms:
275878
Tumors
--Treatment.
LC Class. No.: SF910.T8 / A55 2022
Dewey Class. No.: 636.089/6994
National Library of Medicine Call No.: QZ 266
Animal models for the development of cancer immunotherapy
LDR
:01562cmm a2200325 a 4500
001
650418
003
OCoLC
005
20221202042454.0
006
m o d
007
cr cnu---unuuu
008
240227s2022 nju ob 001 0 eng
020
$a
9781119535331$q(electronic bk.)
020
$a
1119535336$q(electronic bk.)
020
$a
9781119535317$q(epub)
020
$a
111953531X$q(epub)
020
$a
9781119535270$q(ePDF)
020
$a
1119535271$q(ePDF)
020
$z
9781119535287$q(hbk.)
035
$a
1341342966
040
$a
DLC
$b
eng
$c
DLC
$d
YDX
$d
OCLCF
$d
DG1
041
0
$a
eng
050
0 0
$a
SF910.T8
$b
A55 2022
060
0 0
$a
QZ 266
082
0 0
$a
636.089/6994
$2
23
245
0 0
$a
Animal models for the development of cancer immunotherapy
$h
[electronic resource] /
$c
edited by Seng-Lai Tan.
260
$a
Hoboken, NJ :
$b
Wiley,
$c
2022.
300
$a
1 online resource.
504
$a
Includes bibliographical references and index.
520
$a
"There has been an explosion of preclinical and clinical research leading to FDA approvals of immunotherapies that harness or enhance a patient's immune system to target tumors. However, despite promising clinical results, checkpoint blockade therapies can show intrinsic and acquired resistance and only certain tumor types respond more favorably than others. Animal models are valuable tools for studying these issues and for the preclinical evaluation of immune modulators"--
$c
Provided by publisher.
588
$a
Description based on print version record.
650
0
$a
Tumors
$x
Treatment.
$3
275878
650
1 2
$a
Neoplasms
$x
therapy.
$3
197598
650
2 2
$a
Immunotherapy
$x
methods.
$3
340356
650
2 2
$a
Disease Models, Animal.
$3
265387
700
1
$a
Tan, Seng-Lai.
$3
751944
856
4 0
$u
https://onlinelibrary.wiley.com/doi/book/10.1002/9781119535331
筆 0 讀者評論
全部
電子館藏
館藏
1 筆 • 頁數 1 •
1
條碼號
館藏地
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
000000233336
電子館藏
1圖書
電子書
EB SF910.T8 A55 2022 2022
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
多媒體檔案
https://onlinelibrary.wiley.com/doi/book/10.1002/9781119535331
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入